Key result
GeoForm ring implantation in patients with dilated cardiomyopathy resulted in 81.1% overall survival and 85.1% freedom from MR ≥ 3+ at 3.5 years.
Why the study?
Does GeoForm annuloplasty ring implantation improve mitral regurgitation and promote reverse left ventricular remodeling in patients with severe functional mitral regurgitation and advanced dilated cardiomyopathy?
Cohort (n=74)
Does GeoForm annuloplasty ring implantation improve mitral regurgitation and promote reverse left ventricular remodeling in patients with severe functional mitral regurgitation and advanced dilated cardiomyopathy?
The GeoForm annuloplasty ring effectively relieves functional mitral regurgitation and promotes reverse left ventricular remodeling in patients with advanced dilated cardiomyopathy, though preoperative asymmetric tethering predicts recurrence.
May support GeoForm ring use in advanced DCM with FMR; extends observational data but leaves open need for randomized confirmation.
OBJECTIVE: To assess the results of the three-dimensional (3D)-shaped GeoForm ring for the treatment of functional mitral regurgitation (FMR). METHODS: Seventy-four patients with severe FMR and systolic dysfunction underwent GeoForm ring implantation. Forty-six patients (62%) were in the New York Heart Association (NYHA) class III-IV. Concomitant procedures were coronary artery bypass grafting (CABG) (33 patients (pts)), tricuspid repair (23 pts), atrial fibrillation ablation (20 pts), aortic valve replacement (eight pts) and left-ventricular (LV) reconstruction (five pts). RESULTS: Hospital mortality was 9%. Three more patients died after hospital discharge. Overall survival was 81.1 ± 6.6% at 3.5 years. The 67 hospital survivors underwent clinical and echocardiographic follow-up at a mean follow-up period of 1.9 ± 1.25 years (median 1.7 years). MR was absent or mild in 83% of the patients (56/67), moderate in 7% (5/67), and moderate to severe in the remaining 9% (6/67). At 3.5 years, overall freedom from MR ≥ 3+ was 85.1 ± 8% and freedom from MR ≥ 2+ was 75.1 ± 8.6%. Statistical analysis identified preoperative asymmetric tethering with prevalent restricted motion of the posterior leaflet as the only predictor of recurrence of MR ≥ 2+ (hazard ratio (HR) 6.1, p=0.005). Reverse LV remodeling was demonstrated in 31 of the 54 patients eligible for this specific analysis (31/54, 57%): Both LV end-diastolic and end-systolic volumes indexed significantly decreased (both p=0.0001) as well as systolic pulmonary artery pressure (SPAP) (p=0.006). Ejection fraction increased from 33 ± 8% to 43 ± 8% (p<0.0001). Stress echocardiography was performed in a subgroup of eight patients. Mean mitral area at rest was 2.2 ± 0.3 cm² and did not change during stress. Cardiac output significantly increased in all patients during exercise. Although mean and peak transmitral gradients were 3.3 ± 1.3 and 8.1 ± 2.2 mmHg at rest and 6.6 ± 2.5 and 14.8 ± 3.9 mmHg under stress, respectively (both p<0.003), the increase in SPAP was not statistically significant (28 ± 3.0 vs 31 ± 7.5 mm Hg, p=0.17), revealing a preserved cardiac adaptation to exercise. CONCLUSIONS: The GeoForm ring is effective in relieving FMR in most of the patients with dilated cardiomyopathy. In presence of prevalent restricted motion of the posterior leaflet, recurrence of significant MR is more likely to occur. Clinically relevant mitral stenosis was not detected during exercise.
No takes yet. Share an insight, caveat, or question.
Bonis et al. (2011) conducted a cohort in Severe functional mitral regurgitation and systolic dysfunction in advanced dilated cardiomyopathy (n=74). GeoForm annuloplasty ring implantation was evaluated on Overall survival at 3.5 years. GeoForm ring implantation in patients with dilated cardiomyopathy resulted in 81.1% overall survival and 85.1% freedom from MR ≥ 3+ at 3.5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: